Dr. Longo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Cypress St
Brookline, MA 02445Phone+1 857-307-0896Fax+1 410-350-3979
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1977
University of Missouri-Columbia School of MedicineClass of 1975
Certifications & Licensure
MD State Medical License 1977 - 2026
MA State Medical License 1976 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Collection of Bone Marrow Aspirate From Volunteer Donors Start of enrollment: 2002 Jul 01
- PPV: Pneumococcal Polysaccharide Vaccine in Older Adults Start of enrollment: 2001 Apr 01
- Lymphoma Follow-up Start of enrollment: 2003 Oct 01
Publications & Presentations
PubMed
- 1 citationsHodgkin lymphoma: Focus on evolving treatment paradigms.Joseph L Roswarski, Dan L Longo
Best Practice & Research. Clinical Haematology. 2023-12-01 - 2 citationsRegulation of human and mouse bystander T cell activation responses by PD-1.Catherine T Le, Logan V Vick, Craig Collins, Cordelia Dunai, Michael K Sheng
JCI Insight. 2023-09-22 - 15 citationsImmune Checkpoint Inhibitors - The Need for Innovation.P Connor Johnson, Justin F Gainor, Ryan J Sullivan, Dan L Longo, Bruce Chabner
The New England Journal of Medicine. 2023-04-20
Journal Articles
- SARS-CoV-2 Vaccination — an Ounce (Actually, Much Less) of PreventionEric J Rubin, Dan L Longo, The New England Journal of Medicine
- Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint BlockadeR Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature
- Plateletpheresis-Associated Lymphopenia in Frequent Platelet DonorsMichael B Brenner, John M Gansner, A Helena Jonsson, Dan L Longo, Jason M Schenkel, Deepak A Rao, Richard M Kaufman, Nancy Berliner, Duane R Wesemann, Blood
Press Mentions
Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin LymphomaNovember 14th, 2024- Immunotherapy Improves Survival in People with Advanced Hodgkin Lymphoma, Study ShowsOctober 16th, 2024
- Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin’s LymphomaOctober 16th, 2024
- Join now to see all
Grant Support
- The Reveal StudyNational Institute On Aging2009
- Structure-Function Relationship Of NFKB P65National Institute On Aging2009
- Shaping The Preimmune B Cell RepertoireNational Institute On Aging2009
- Role Of Hyperplasia Suppressor Gene (HSG) In Cell Growth.National Institute On Aging2009
- Rapamycin-Sensitive Pathway Of T Cell ActivationNational Institute On Aging2009
- Long-Term Consequences Of Lymphoma And Its TreatmentNational Institute On Aging2009
- Cytapheresis Of Volunteer Donors (Mri 2003-054)National Institute On Aging2009
- Characterization Of Tgf-B Signaling In A B-Cell Lymphoma Cell LINENational Institute On Aging2009
- Acute Leukemia In The Elderly: Development Of Novel, Targeted TherapeuticsNational Institute On Aging2009
- Acute Leukemia In The Elderly: Development Of Novel, Targeted TherapeuticsNational Institute On Aging2008
- Characterization Of Tgf-B Signaling In A B-Cell Lymphoma Cell LINENational Institute On Aging2007–2008
- Structure-Function Relationship Of NFKB P65National Institute On Aging2005–2008
- Rapamycin-Sensitive Pathway Of T Cell ActivationNational Institute On Aging2005–2008
- Shaping The Preimmune B Cell RepertoireNational Institute On Aging2002–2008
- Tumor-Induced ImmunosuppressionNational Institute On Aging2002–2007
- Cell Biology Of LymphomaNational Institute On Aging2000–2007
- Characterization Of Tgf-B Signaling In A B-Cell LymphomaNational Institute On Aging2006
- Characterization Of Tgf-B Signaling In B-Cell LymphomaNational Institute On Aging2005
- Role Of SMAD3 In Tgf-B Signaling In A B-Cell Lymphoma CENational Institute On Aging2004
- Role Of PTEN In T Cell ActivationNational Institute On Aging2002–2004
- Cyclosporin A-Resistant Co-Stimulation VIA CD28National Institute On Aging2002–2004
- Regulation Of Mutant P53National Institute On Aging2000–2004
- SMAD3 In Tgf-B Signaling In B Cell Lymphoma Cell LINENational Institute On Aging2003
- SMAD3 In Tgf-B Signaling In A B-Cell Lymphoma Cell LINENational Institute On Aging2002
- Regulation Of Interferon-Gamma Gene In Freshly DifferentNational Institute On Aging2002
- Regulation Of Interferon-Gamma Gene In TH1 And TH2 CellsNational Institute On Aging2001
- Cyclosporin A Resistant Costimulation VIA CD28National Institute On Aging2001
- Tumor Induced ImmunosuppressionNational Institute On Aging2000–2001
- Role Of Cadherins In Tumor ProgressionNational Institute On Aging2000–2001
- Role Of SAP In Lymphocyte Sub PopulationsNational Institute On Aging2000
- Cyclosporin A Resistant CO Stimulation VIA CD28National Institute On Aging2000
- Host Tumor InteractionsNational Institute On Aging1999
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
